Offer - Urjas Oil for just ₹ 1 X
T Glip M 500 Tablet ER (15) is a prescription drug, available for use as Tablet. The alternative uses of T Glip M 500 Tablet ER (15) have also been explained below.
The right dosage of T Glip M 500 Tablet ER (15) depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
T Glip M 500 Tablet ER (15) also has some side effects, the most common being Stomach Upset, Difficulty urinating, Hypoglycemia (Low blood sugar level). Besides the aforementioned side effects, there are other adverse effects of T Glip M 500 Tablet ER (15) as well, which are listed below. Usually, these side effects of T Glip M 500 Tablet ER (15) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of T Glip M 500 Tablet ER (15) is Moderate for pregnant women and Severe for women who are breastfeeding. It is important to know if T Glip M 500 Tablet ER (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the T Glip M 500 Tablet ER (15) related warnings section.
Individuals suffering from medical conditions like Congestive Heart Failure (CHF), Anemia, Shock must refrain from the use of T Glip M 500 Tablet ER (15) since this can cause severe adverse effects. The section on T Glip M 500 Tablet ER (15) contraindications lists all such conditions.
Drug interactions for T Glip M 500 Tablet ER (15) have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that T Glip M 500 Tablet ER (15) is safe while driving, and is is addictive in nature.
T Glip M 500 Tablet ER (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of T Glip M 500 Tablet ER (15) safe for pregnant women?
Tglip M may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Tglip M again without your doctor's advice.
Is the use of T Glip M 500 Tablet ER (15) safe during breastfeeding?
Taking Tglip M may lead to serious side effects if you are breastfeeding. Tglip M should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of T Glip M 500 Tablet ER (15) on the Kidneys?
There is no research available on the side effects of Tglip M on kidney. Therefore, its impact is unknown.
What is the effect of T Glip M 500 Tablet ER (15) on the Liver?
Information about safety of Tglip M for the liver is not available since scientific research on this is yet to be done.
What is the effect of T Glip M 500 Tablet ER (15) on the Heart?
Information about safety of Tglip M for heart is not available since scientific research on this is yet to be done.
T Glip M 500 Tablet ER (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take T Glip M 500 Tablet ER (15) unless your doctor advises you to do so -
Is this T Glip M 500 Tablet ER (15) habit forming or addictive?
No, you will not get addicted to T Glip M 500 Tablet ER (15).
Interaction between Food and T Glip M 500 Tablet ER (15)
Information is not available on the interaction of any foods with T Glip M 500 Tablet ER (15), due to a lack of research on this.
Interaction between Alcohol and T Glip M 500 Tablet ER (15)
Information about the interaction of T Glip M 500 Tablet ER (15) and alcohol is not currently available because this topic has not been researched yet.
Tglip M is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
Yes, Tglip M can be taken with the statin. There is no serious or harmful interaction have been observed between them. Some studies say that it's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. The risk is small but important enough that the Food and Drug Administration (FDA) has issued a warning on statin labels regarding blood glucose levels and diabetes.
Yes, Tglip M commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Tglip M with your meal and increase the dose gradually.
Tglip M contain metformin, is an oral antidiabetic drug which belongs to the class of biguanide. It is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Moreover, it also reduces the risk of cardiovascular complications of diabetes.
Yes, Tglip M is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826